NCT07850102Not yet recruitingPhase 2
Brain Imaging of DSP-2342
Source: ClinicalTrials.gov · Last updated 30 Sept 2026
Brief summary (registry, in English)
The investigators aim to determine the effects of a novel drug on brain function and brain chemistry in patients with schizophrenia.
- Status (registry)
- Not yet recruiting
- Phase (registry)
- Phase 2
- Study type
- Interventional
- Enrollment
- 20 (estimated)
- First submitted
- 24 Sept 2026
- Start date
- 1 Jan 2027
- Primary completion date
- 31 Dec 2027
- Lead sponsor
- Johns Hopkins University
- Diseases
- Schizophrenia
- NCT number
- NCT07850102
What you commit to
- Study type: Interventional · Phase 2
- Planned participants: 20
- From 1 Jan 2027 to the primary completion date, 31 Dec 2027
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- Having a contraindication to MRI, including a pacemaker, defibrillator or other medical implant, other metal objects, or claustrophobia, or for having braces or other metal in the head region (likely to create an artifact on the MRI scans).
- Medication changes in the past six weeks
Other illness
- Subjects with renal impairment
- Subjects with hepatic impairment
- Past or current neurological disorder (including stroke, brain tumor, epilepsy, Alzheimer's, Parkinson's or Huntington's disease)
- Non-schizophrenia cause of cognitive impairment
- Uncontrolled medical disorder that may interfere with cognition or compromise safety
- Head trauma with loss of consciousness in the last year or any evidence of functional impairment due to and persisting after head trauma
- Recent history of electroconvulsive therapy
Lab values
- Subjects with electrocardiographic abnormalities (particularly QTc prolongation)
Other
- Current substance misuse
- Pregnancy or breast feeding
- Significant suicidal ideation
Who the study is looking for
- right-handed, participants with schizophrenia between the ages of 18-50 years.
Age in the registry: 18 years to 50 years · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Johns Hopkins University Coordinator of this site? Confirm its status | Baltimore | United States | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.